←Back to structures
MH431936.1__AXF39696.1__KAWIKA_54__00054
Bact-VirMH431936.1__AXF39696.1__KAWIKA_54__00054
Identity
- Accession:
- MH431936 ↗
- Kingdom:
- phage
Quality
84.1
mean pLDDT
Taxonomy
TaxID: 2249777
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
medium
residues 1-73
Domain cluster:
rep: MH431936.1__AXF39680.1__KAWIKA_56__00056__DFULL
CATH (5)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2csvA00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.63 | 42.0 | 4.28e-01 | 78.1% | 70.8% |
| 5feyA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.60 | 48.0 | 4.70e-01 | 89.0% | 93.6% |
| 3i2dA02 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.58 | 50.0 | 4.31e-01 | 100.0% | 64.5% |
| 4gi3C00 | 3.30.60.30 | Alpha Beta › 2-Layer Sandwich › Wheat Germ Agglutinin (Isolectin 2); domain 1 › | 0.54 | 35.0 | 3.81e-01 | 83.6% | 84.2% |
| 1x0cA01 | 2.60.350.10 | Mainly Beta › Sandwich › Dex49a from penicillium minioluteum complex, domain 1 › Dextranase, N-terminal | 0.50 | 35.0 | 2.82e-01 | 76.7% | 71.3% |
ECOD (19)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3344003 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.74 | 51.0 | 4.94e-01 | 71.2% | 86.3% |
| 3751810 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.71 | 50.0 | 4.20e-01 | 74.0% | 72.0% |
| 3221968 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.66 | 37.0 | 4.31e-01 | 71.2% | 80.0% |
| 3623052 | 376.1.1.5 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-UBP | 0.66 | 48.0 | 4.11e-01 | 78.1% | 64.2% |
| 3661154 | 376.1.1.70 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Sina_RING | 0.65 | 54.0 | 5.15e-01 | 91.8% | 88.2% |
| 3684718 | 376.1.1.11 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › COPI_C | 0.64 | 43.0 | 4.87e-01 | 75.3% | 92.7% |
| 3305271 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.64 | 49.0 | 4.57e-01 | 80.8% | 93.3% |
| 3392386 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.64 | 50.0 | 5.30e-01 | 84.9% | 95.4% |
| 3787741 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.62 | 44.0 | 4.76e-01 | 80.8% | 95.0% |
| 3638393 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.61 | 45.0 | 4.52e-01 | 79.5% | 94.7% |
| 4000496 | 6171.1.1.0 ↗ | alpha bundles › C-terminal helical domain in Jumonji domain-containing histone demethylases › C-terminal helical domain in Jumonji domain-containing histone demethylases › C-terminal helical domain in Jumonji domain-containing histone demethylases | 0.59 | 41.0 | 3.00e-01 | 90.4% | 26.5% |
| 3858618 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.59 | 46.0 | 4.55e-01 | 87.7% | 98.8% |
| 4451053 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.59 | 36.0 | 4.05e-01 | 83.6% | 88.0% |
| 3869469 | 377.1.1.0 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like | 0.59 | 45.0 | 3.67e-01 | 83.6% | 50.7% |
| 3413459 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.57 | 35.0 | 3.95e-01 | 86.3% | 91.8% |
| 3865569 | 379.1.1.3 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_2 | 0.56 | 35.0 | 3.68e-01 | 76.7% | 70.8% |
| 3800199 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.53 | 37.0 | 3.55e-01 | 76.7% | 61.4% |
| 3861316 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.52 | 35.0 | 3.78e-01 | 72.6% | 92.6% |
| 3556588 | 379.1.1.4 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors › Kazal_3 | 0.52 | 34.0 | 3.79e-01 | 71.2% | 92.6% |